checkAd
    Startseite > Aktien > Pyxis Oncology > Nachrichten
    Pyxis Oncology Aktie
    4,3400
     
    USD
    -3,77 %
    -0,1700 USD
    Letzter Kurs 02:00:00 Nasdaq
    4,3200
     
    USD
    700 STK
    Geldkurs 10.05.24
    4,3400
     
    USD
    400 STK
    Briefkurs 10.05.24
    ISIN: US7473241013 · WKN: A3C45M · SYM: PYXS · USA

    Neueste Nachrichten

    Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
    09.05.24 · globenewswire · Pyxis Oncology
    Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    28.03.24 · globenewswire · Pyxis Oncology
    Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
    27.03.24 · globenewswire · Pyxis Oncology
    Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
    21.03.24 · globenewswire · Pyxis Oncology
    Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
    13.03.24 · globenewswire · Pyxis Oncology
    Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
    07.03.24 · globenewswire · Pyxis Oncology
    Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
    05.03.24 · globenewswire · Pyxis Oncology
    Pyxis Oncology Announces $50 Million Private Placement
    27.02.24 · globenewswire · Pyxis Oncology
    Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    29.12.23 · globenewswire · Pyxis Oncology
    Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
    28.11.23 · globenewswire · Pyxis Oncology
    Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
    07.11.23 · globenewswire · Pyxis Oncology
    Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
    27.09.23 · globenewswire · Pyxis Oncology